[Usefulness of nuclear techniques in the study of myocardial viability]

Erick Alexánderson1

  • 1Departamento de Medicina Nuclear, Instituto Nacional de Cardiología Ignacio Chávez, Unidad PET-Ciclotrón, Facultad de Medicina, UNAM, México, D.F. alexanderick@yahoo.com

Insights

Assessing myocardial viability in coronary artery disease patients with left ventricular dysfunction aids risk stratification. Identifying viable heart muscle can predict benefits from revascularization, improving survival and heart function.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Assessing myocardial viability is crucial for diagnosing and predicting outcomes in patients with coronary artery disease (CAD) and left ventricular dysfunction.
  • Identifying viable myocardium aids in risk stratification, identifying patients who may benefit from revascularization procedures.
  • Revascularization of viable but dysfunctional heart segments in CAD patients is linked to improved survival and New York Heart Association (NYHA) functional class.

Purpose of the Study:

  • To evaluate the diagnostic and prognostic value of myocardial viability assessment in patients with coronary artery disease and left ventricular dysfunction.
  • To determine the role of myocardial viability identification in predicting the benefits of revascularization.
  • To compare the effectiveness of different non-invasive imaging techniques for assessing myocardial viability.

Main Methods:

  • Utilized nuclear cardiology methods, specifically Thallium-201 single-photon emission computed tomography (TI-201 SPECT) imaging (stress-redistribution-reinjection).
  • Compared TI-201 SPECT with 18-Fluorodeoxyglucose Positron Emission Tomography (18-FDG PET), considered the gold standard.
  • Reviewed studies correlating imaging findings with patient outcomes, including survival and functional class.

Main Results:

  • TI-201 SPECT is a commonly used, cost-effective method for assessing myocardial viability with good correlation to 18-FDG PET.
  • Revascularization of viable myocardial segments in patients with CAD and left ventricular dysfunction has been associated with improved survival and NYHA class.
  • Improvements in both global and regional left ventricular function have been observed following revascularization of viable segments.

Conclusions:

  • Myocardial viability assessment is vital for risk stratification and guiding revascularization decisions in CAD patients with left ventricular dysfunction.
  • 18-FDG PET is the gold standard for myocardial viability assessment and should be used when available in patients with moderate to severe left ventricular dysfunction.
  • Nuclear cardiology techniques, particularly TI-201 SPECT, are valuable tools for assessing myocardial viability, offering a balance of availability, cost, and diagnostic accuracy.

Related Concept Videos

Applications Of NMR In Biology01:25

Applications Of NMR In Biology

Nuclear magnetic resonance (NMR) spectroscopy is a very valuable analytical technique for researchers. It has been used for more than 50 years as an analytical tool. F. Bloch and E. Purcell formulated NMR in 1946 and won the 1952 Nobel Prize in Physics  for their work. Biological macromolecules such as proteins, nucleic acids, lipids, and organic molecules including pharmaceutical compounds, can be studied using this versatile tool that exploits the magnetic properties of certain nuclei.
The...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...